1. Bernard P, Vaillant L, Martin C, Beylot C, Quantin R, Touron D: Pristinamycine (Pyostacine 500R) versus oxacilline (BristopenR) dans le traitement des pyodermites superficielles.Ann Dermatol Venereol 1997;124:384-389.
2. Swartz MN: Skin and soft tissue infections; in Mandell GL, Bennett JE, Dolin R (eds): Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, ed 4. New York, Churchill-Livingstone, 1995, section I (72), pp 909-927.
3. Bouvet A, Aubry-Damon H, Pean Y: Emergence de la resistance aux macrolides des Streptococcus pyogenes ou streptocoques beta-hemolytiques du groupe A. Bull Epidemiol Hebd 2004;32-33:154-155.
4. Lorette G, Beaulieu P, Bismuth R, Duru G, Guihard W, Lemaitre M, Janin N, Jarlier V: Infections cutanees communautaires: bacteries en cause et sensibilite aux antibiotiques. Ann Dermatol Venereol 2003;130:723-728.
5. Mechanisms responsible for the blood level differences of isoxazolyl penicillins: oxacillin, cloxacillin, and dicloxacillin